Page 9 - Biocon Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biocon posts Rs 257 crore profit for Q4 on strong biosimilar business ANI | Updated: Apr 29, 2021 12:58 IST Bengaluru (Karnataka) [India], April 29 (ANI): Biopharmaceuticals major Biocon Ltd on Thursday reported net profit of Rs 257 crore in the fourth quarter of FY21, up 95 per cent from Rs 132 crore in Q4 FY20. The was largely driven by biosimilars, research services and generics businesses. The company's Q4 FY21 consolidated revenue grew 26 per cent to Rs 2,044 crore from Rs 1,621 crore in Q4 FY20. Earnings before interest, taxes, depreciation and amor...

Biocon Biologics’ new monoclonal antibodies facility bags ISPE’s 2021 award April 28, 2021 × This is the first time that a biopharma company from India has been awarded an ISPE FOYA mention Biocon Biologics Ltd, a fully integrated ‘pure play’ biosimilars company and a subsidiary of Biocon Ltd, has announced that it has been awarded with the 2021 Facility of the Year Award (FOYA) from the International Society for Pharmaceutical Engineering (ISPE). The company received an Honorable Mention award for its monoclonal antibodies drugs substances manufacturing facility located at Biocon...

Results: Biocon’s revenue up at Rs 2,044 crore in Q4 of FY21 Results: Biocon’s revenue up at Rs 2,044 crore in Q4 of FY21 Bangalore-based Biocon reported a 26 per cent rise in consolidated revenue from Rs 1,621 crore in Q4FY20 to Rs 2,044 crore in Q4FY 2021. Indian biopharmaceutical company registered a net profit of over 100 per cent, at Rs 254 crore in Q4FY20. The consolidated revenue grew 14 per cent to Rs 7,360 crore in FY21 from Rs 6,462 crore in FY20. In FY21, the net profit (before exceptional item and discontinuing operations) was at Rs 754 crore was down 4 per cent. The net...

Booster shot: India Inc plans Covid-19 jabs for staff, families Our Bureau New Delhi/Mumbai | Updated on April 21, 2021 Companies feel that there is a need for more clarity on availability, pricing of vaccines   -  MURALI KUMAR K Companies feel that there is a need for more clarity on availability, pricing of vaccines   -  MURALI KUMAR K× To help employees as vaccination is not covered, as part of the health insurance, under OPD policy Following the Centre’s decision to allow partial sale of the Covid-19 vaccines in the open market, India Inc has started chalking out plans to get its s...

The Biocon Group is the 1st Corporate entity to kickstart this vaccination centre in Bengaluru